Rockley Group
Rockley Group is a venture capital firm based in Oxford, United Kingdom, with additional offices in Shanghai, China. Founded in 2004, it specializes in growth capital, expansion capital, and late-stage investments. The firm primarily focuses on sectors such as sustainability, energy, information technology, healthcare, and industrial efficiency, as well as emerging opportunities in the agricultural and environmental technology sectors. Rockley Group aims to build valuable companies that contribute to global sustainability and enhance human well-being. It typically invests between €5 million and €15 million per transaction, primarily targeting businesses in the United Kingdom and China, with a specific emphasis on the Shandong and Shanxi regions in China.
Rockley Photonics Limited, founded in 2013 and headquartered in Pasadena, California, specializes in the development of silicon photonics technologies for various applications, including data communications and consumer products. The company manufactures photonic chips and custom integrated packaged products, focusing on both chipset sales and customer-specific designs. Rockley Photonics integrates its research and development efforts to create a comprehensive range of optical modules that include supporting electronics, software, application algorithms, and AI platforms. These offerings are tailored for high-volume applications across dynamic and growing market sectors, demonstrating the company's commitment to innovation in photonics technology.
CHAIN Biotechnology Ltd. is a biotechnology company that specializes in developing and utilizing Clostridium bacteria for various applications, leveraging recent advancements in synthetic biology and automation to enhance fermentation processes. The company focuses on producing chiral chemicals, which are essential for a variety of products such as nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Among its key developments are 3-hydroxybutyrate, a versatile chiral molecule, and (R)-methyl-3HB, a precursor chemical for the glaucoma treatment dorzolamide. Additionally, CHAIN Biotechnology is exploring cost-effective fermentation methods using sugar as a substrate. The company's expertise encompasses microbiology, molecular biology tools, and microbial strain development. Founded in 2014 and headquartered in London, United Kingdom, CHAIN Biotechnology is also engaged in developing therapeutic compounds aimed at addressing chronic gut-related diseases through its innovative drug development platform.
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.
KOTURA, Inc. specializes in silicon photonics, focusing on the design, manufacture, and marketing of CMOS optical components that facilitate the integration of optics in the communications industry. The company offers custom chip design, fabrication, and packaging services, leveraging its technology platform to combine optical and optoelectronic functionalities. This enables the creation of application-specific integrated circuits (ASICs) tailored for various applications, including data center interconnects, computing, and telecommunications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.